ELITE II and Val-HeFT are different trials: together what do they tell us?
about
Valsartan for the treatment of heart failure.Heart failure drug utilization patterns for Medicaid patients before and after a heart failure-related hospitalization.Angiotensin II type 1 receptor antagonists in the treatment of hypertension in elderly patients: focus on patient outcomes.How to adjust ACE inhibitors and ARBs in diabetes?What constitutes optimal neurohumoral antagonism in chronic heart failure?
P2860
ELITE II and Val-HeFT are different trials: together what do they tell us?
description
2001 nî lūn-bûn
@nan
2001 թուականին հրատարակուած գիտական յօդուած
@hyw
2001 թվականին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
ELITE II and Val-HeFT are different trials: together what do they tell us?
@ast
ELITE II and Val-HeFT are different trials: together what do they tell us?
@en
ELITE II and Val-HeFT are different trials: together what do they tell us?
@nl
type
label
ELITE II and Val-HeFT are different trials: together what do they tell us?
@ast
ELITE II and Val-HeFT are different trials: together what do they tell us?
@en
ELITE II and Val-HeFT are different trials: together what do they tell us?
@nl
prefLabel
ELITE II and Val-HeFT are different trials: together what do they tell us?
@ast
ELITE II and Val-HeFT are different trials: together what do they tell us?
@en
ELITE II and Val-HeFT are different trials: together what do they tell us?
@nl
P2860
P356
P1476
ELITE II and Val-HeFT are different trials: together what do they tell us?
@en
P2860
P2888
P304
P356
10.1186/CVM-2-5-240
P577
2001-01-01T00:00:00Z
P5875
P6179
1052053238